Children with growth hormone deficiency (GHD) had reduced physical fitness and lower levels of physical activity than control individuals without the condition, but 1 year of growth hormone ...

(Family Features) Pediatric growth hormone deficiency (GHD) is a relatively rare condition, affecting an estimated 1 in 4,000-10,000 children. Despite its rarity, GHD can significantly impact a ...

Cisplatin, Gemcitabine, and Ifosfamide As Weekly Therapy: A Feasibility and Phase II Study of Salvage Treatment for Advanced Transitional-Cell Carcinoma PURPOSE: Little is known about the long-term ...

What began as a single clinic in Colorado has evolved into a well-regarded provider of hormone optimization and replacement care, now serving more than 10,000 patients.

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...

For more than 20 years, hormone therapy for menopause has carried a warning label from the Food and Drug Administration ...

Hormone therapy for breast cancer slows or stops the growth of hormone-sensitive tumors and is not the same as hormone replacement therapy.

Once a diagnosis is confirmed, children with PGHD often work closely with an endocrinologist to develop a treatment plan that includes growth hormone replacement therapy and closely monitor future ...